Logo image of BLMN

BLOOMIN' BRANDS INC (BLMN) Stock Fundamental Analysis

NASDAQ:BLMN - Nasdaq - US0942351083 - Common Stock - Currency: USD

8.79  +0.23 (+2.69%)

After market: 9.09 +0.3 (+3.41%)

Fundamental Rating

3

Overall BLMN gets a fundamental rating of 3 out of 10. We evaluated BLMN against 135 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of BLMN have multiple concerns. BLMN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BLMN had positive earnings in the past year.
In the past year BLMN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BLMN reported negative net income in multiple years.
BLMN had a positive operating cash flow in each of the past 5 years.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

With a Return On Assets value of -3.78%, BLMN is not doing good in the industry: 72.59% of the companies in the same industry are doing better.
BLMN's Return On Equity of -94.47% is on the low side compared to the rest of the industry. BLMN is outperformed by 63.70% of its industry peers.
BLMN's Return On Invested Capital of 6.63% is in line compared to the rest of the industry. BLMN outperforms 59.26% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BLMN is significantly below the industry average of 15.93%.
Industry RankSector Rank
ROA -3.78%
ROE -94.47%
ROIC 6.63%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.57%
ROIC(5y)N/A
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

BLMN has a worse Operating Margin (5.17%) than 62.22% of its industry peers.
BLMN's Operating Margin has improved in the last couple of years.
BLMN has a Gross Margin of 70.94%. This is amongst the best in the industry. BLMN outperforms 85.93% of its industry peers.
BLMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.17%
PM (TTM) N/A
GM 70.94%
OM growth 3Y-17.88%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BLMN is creating some value.
Compared to 1 year ago, BLMN has less shares outstanding
Compared to 5 years ago, BLMN has less shares outstanding
BLMN has a worse debt/assets ratio than last year.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.90, we must say that BLMN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.90, BLMN is not doing good in the industry: 68.89% of the companies in the same industry are doing better.
BLMN has a debt to FCF ratio of 140.42. This is a negative value and a sign of low solvency as BLMN would need 140.42 years to pay back of all of its debts.
BLMN has a Debt to FCF ratio of 140.42. This is in the lower half of the industry: BLMN underperforms 64.44% of its industry peers.
BLMN has a Debt/Equity ratio of 7.64. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 7.64, BLMN is not doing good in the industry: 62.22% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 7.64
Debt/FCF 140.42
Altman-Z 0.9
ROIC/WACC0.73
WACC9.04%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.34 indicates that BLMN may have some problems paying its short term obligations.
The Current ratio of BLMN (0.34) is worse than 83.70% of its industry peers.
BLMN has a Quick Ratio of 0.34. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
BLMN's Quick ratio of 0.26 is on the low side compared to the rest of the industry. BLMN is outperformed by 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.26
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1

3. Growth

3.1 Past

BLMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.14%.
Measured over the past 5 years, BLMN shows a small growth in Earnings Per Share. The EPS has been growing by 3.30% on average per year.
Looking at the last year, BLMN shows a very negative growth in Revenue. The Revenue has decreased by -15.43% in the last year.
BLMN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.93% yearly.
EPS 1Y (TTM)-38.14%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-49.33%
Revenue 1Y (TTM)-15.43%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-18.6%

3.2 Future

Based on estimates for the next years, BLMN will show a small growth in Earnings Per Share. The EPS will grow by 6.83% on average per year.
The Revenue is expected to decrease by -3.21% on average over the next years.
EPS Next Y0.52%
EPS Next 2Y7.19%
EPS Next 3Y6.83%
EPS Next 5YN/A
Revenue Next Year-11.7%
Revenue Next 2Y-5.21%
Revenue Next 3Y-3.21%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.88, the valuation of BLMN can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 98.52% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BLMN to the average of the S&P500 Index (29.35), we can say BLMN is valued rather cheaply.
A Price/Forward Earnings ratio of 4.86 indicates a rather cheap valuation of BLMN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 99.26% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, BLMN is valued rather cheaply.
Industry RankSector Rank
PE 4.88
Fwd PE 4.86
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 95.56% of the companies listed in the same industry.
BLMN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 100.95
EV/EBITDA 4.52
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BLMN does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)9.42
PEG (5Y)1.48
EPS Next 2Y7.19%
EPS Next 3Y6.83%

6

5. Dividend

5.1 Amount

BLMN has a Yearly Dividend Yield of 7.01%, which is a nice return.
The stock price of BLMN dropped by -31.81% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.25, BLMN pays a better dividend. On top of this BLMN pays more dividend than 96.30% of the companies listed in the same industry.
BLMN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 7.01%

5.2 History

The dividend of BLMN is nicely growing with an annual growth rate of 19.12%!
BLMN has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BLMN decreased in the last 3 years.
Dividend Growth(5Y)19.12%
Div Incr Years1
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BLMN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of BLMN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-64.5%
EPS Next 2Y7.19%
EPS Next 3Y6.83%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BLOOMIN' BRANDS INC

NASDAQ:BLMN (3/7/2025, 8:07:55 PM)

After market: 9.09 +0.3 (+3.41%)

8.79

+0.23 (+2.69%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)05-05 2025-05-05/bmo
Inst Owners107.14%
Inst Owner Change-3.87%
Ins Owners1.47%
Ins Owner Change5.39%
Market Cap746.53M
Analysts54.44
Price Target13.13 (49.37%)
Short Float %13.38%
Short Ratio5.38
Dividend
Industry RankSector Rank
Dividend Yield 7.01%
Yearly Dividend0.96
Dividend Growth(5Y)19.12%
DP-64.5%
Div Incr Years1
Div Non Decr Years2
Ex-Date03-11 2025-03-11 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.82%
Min EPS beat(2)0.68%
Max EPS beat(2)2.96%
EPS beat(4)2
Avg EPS beat(4)-4.47%
Min EPS beat(4)-13.76%
Max EPS beat(4)2.96%
EPS beat(8)6
Avg EPS beat(8)1.77%
EPS beat(12)10
Avg EPS beat(12)2.87%
EPS beat(16)13
Avg EPS beat(16)11.54%
Revenue beat(2)0
Avg Revenue beat(2)-7.12%
Min Revenue beat(2)-11.95%
Max Revenue beat(2)-2.28%
Revenue beat(4)0
Avg Revenue beat(4)-4.74%
Min Revenue beat(4)-11.95%
Max Revenue beat(4)-2.1%
Revenue beat(8)1
Avg Revenue beat(8)-3.18%
Revenue beat(12)2
Avg Revenue beat(12)-2.68%
Revenue beat(16)4
Avg Revenue beat(16)-2.15%
PT rev (1m)-16.49%
PT rev (3m)-26.08%
EPS NQ rev (1m)-3.54%
EPS NQ rev (3m)-3.36%
EPS NY rev (1m)-0.83%
EPS NY rev (3m)-2.32%
Revenue NQ rev (1m)-1.84%
Revenue NQ rev (3m)-0.62%
Revenue NY rev (1m)-7.62%
Revenue NY rev (3m)-7.21%
Valuation
Industry RankSector Rank
PE 4.88
Fwd PE 4.86
P/S 0.19
P/FCF 100.95
P/OCF 3.27
P/B 5.51
P/tB N/A
EV/EBITDA 4.52
EPS(TTM)1.8
EY20.48%
EPS(NY)1.81
Fwd EY20.58%
FCF(TTM)0.09
FCFY0.99%
OCF(TTM)2.69
OCFY30.56%
SpS46.51
BVpS1.6
TBVpS-5.97
PEG (NY)9.42
PEG (5Y)1.48
Profitability
Industry RankSector Rank
ROA -3.78%
ROE -94.47%
ROCE 8.39%
ROIC 6.63%
ROICexc 6.83%
ROICexgc 9.37%
OM 5.17%
PM (TTM) N/A
GM 70.94%
FCFM 0.19%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.57%
ROIC(5y)N/A
ROICexc(3y)9.95%
ROICexc(5y)N/A
ROICexgc(3y)14.55%
ROICexgc(5y)N/A
ROCE(3y)12.12%
ROCE(5y)N/A
ROICexcg growth 3Y-22.71%
ROICexcg growth 5Y1.91%
ROICexc growth 3Y-20.67%
ROICexc growth 5Y2.33%
OM growth 3Y-17.88%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
F-Score4
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 7.64
Debt/FCF 140.42
Debt/EBITDA 2.73
Cap/Depr 125.72%
Cap/Sales 5.59%
Interest Coverage 3.4
Cash Conversion 60.09%
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.26
Altman-Z 0.9
F-Score4
WACC9.04%
ROIC/WACC0.73
Cap/Depr(3y)141.63%
Cap/Depr(5y)109.75%
Cap/Sales(3y)6.11%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.14%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-49.33%
EPS Next Y0.52%
EPS Next 2Y7.19%
EPS Next 3Y6.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.43%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-18.6%
Revenue Next Year-11.7%
Revenue Next 2Y-5.21%
Revenue Next 3Y-3.21%
Revenue Next 5YN/A
EBIT growth 1Y-44.02%
EBIT growth 3Y-19.03%
EBIT growth 5Y0.67%
EBIT Next Year60.67%
EBIT Next 3Y19.08%
EBIT Next 5YN/A
FCF growth 1Y-96.45%
FCF growth 3Y-70.21%
FCF growth 5Y-45.63%
OCF growth 1Y-57.15%
OCF growth 3Y-17.24%
OCF growth 5Y-6.4%